Event Type
Disclosure
Voluntary
Variant
8-K
. The information in this Item 7.01, including Exhibit 99.1 and the information on the Company’s website, shall not be deemed “filed” for purposes of Section 18
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Actuate Therapeutics, Inc. dated January 12, 2026 104 Cover Page I